A randomized controlled trial in HIV-positive youths aged 18-25 years enrolled participants based on cART treatment with TDF ( TDF ; n = 118 ) or without TDF ( no-TDF ; n = 85 ) , and randomized within those groups to VITD ( 50,000 IU every 4 weeks ) or placebo ( PL ) .